Singapore: US FDA has accepted Actavis' New Drug Application (NDA) for a progestin-only transdermal contraceptive patch (Norethindrone Transdermal Delivery System) for use by women to prevent pregnancy. The acceptance of the NDA for... Read more
Singapore: Gilead Sciences' phase II study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational, targeted,... Read more
Singapore: BioDuro, a PPD Company, has opened a new state-of-the-art laboratory in Shanghai, China, strengthening its ability... Read more
Singapore: Antisense Therapeutics, an Australian publicly listed biopharmaceutical drug discovery and development company, will conduct... Read more
Singapore: Alcon, the global leader in eye care and a division of Novartis, has received European Commission's approval for Jetrea intravitreal... Read more
Singapore: Dainippon Sumitomo Pharma (DSP), headquartered in Japan, and Nippon Shinyaku, also a Japanese company, have concluded a license... Read more
Singapore: Japanese company Daiichi Sankyo has received positive results for a double-blind randomized phase III trial comparing efficacy... Read more
Singapore: Vanda Pharmaceuticals has withdrawn its application from European Medicines Agency for a centralized marketing authorization... Read more
Singapore: Autism results from abnormal cell communication. Testing a new theory, researchers at the University of California, San Diego... Read more
A meeting between Dr Teo Soo Hwang, current CEO of AseaCyte; Dr Lee Hong Boon from Cancer Research Initiatives Foundation (CARIF), a non-profit... Read more
Singapore: Recent worries over antibiotics losing their effectiveness will only be exacerbated by the FDA's latest drug safety update which... Read more
Singapore: The Scripps Research Institute (TSRI) and Takeda Pharmaceutical plan to expand their recent research collaboration to search... Read more
Survey Box